Selected Studies & White Papers

Oral

Activation of Telomerase by TA-65 Enhances Immunity and Reduces Inflammation Post Myocardial Infarction
Double-blind, Placebo-controlled, Randomized Clinical Trial Demonstrates Telomerase Activator TA-65® Decreases Immunosenescent CD8+CD28- T Cells In Humans
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
First Randomized, Double-Blind, Placebo-Controlled Study to Show Telomere Lengthening in Humans
TA-65® reduces the telomere loss that accompanies normal aging
Demonstrated Improvement of Prematurely Aged Skin by Oral Intake of TA-65®
Genetic Epidemiology Research on Adult Health and Aging (GERA) Study
Experimental increase in telomere length leads to faster feather regeneration
A Natural Product Telomerase Activator As Part of a Health Maintenance Program
Functional Assessment of Pharmacological Telomerase Activators in Human T Cells
The telomerase activator TA-65 elongates short telomeres and increases health span of adult⁄old mice without increasing cancer incidence
A Natural Product Telomerase Activator as Part of a Health Maintenance Program: Metabolic and Cardiovascular Response
Telomerase reactivation reverses tissue degeneration in aged telomerase deficient mice

Topical

Scholarly Articles